Commercial satellites dock mid-space for servicing mission

When researchers discovered enough proof that a medication used to treat bone marrow cancer and Kaposi sarcoma is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that affects 1 in 5,000 people worldwide, they decided to terminate an early clinical trial funded by the National Institutes of Health

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes

Swedish researchers have developed a microscale device for implantation in the eye, potentially opening up new avenues for cell-based treatment of diabetes and other diseases.

Studies show that a change in the way we view the advantages mangroves have for coastal areas might lead to huge gains in biodiversity and the economy, as well as the protection of millions of people from flooding. According to a study led by the University of Queensland, present conservation efforts often focus on biodiversity protection while reducing confrontation with commercial interests, while failing to account for the enormous advantages supplied by ecosystems.

According to new research, severe hypoglycemia is more than twice as likely among persons with diabetes who struggle to purchase meals.

According to a recent study led by scientists at the Harvard Pilgrim Health Care Institute, SARS-CoV-2 accounted for 1 in 6 occurrences of sepsis over the first 33 months of the COVID-19 pandemic, highlighting the importance of viral sepsis.

The interesting TRAPPIST-1 exoplanetary system was initially found in 2016 amid speculation that it might one day be a home for mankind. Astronomers working under the direction of a team at the Université de Montréal have made significant progress in studying this system.

The innovative device, which is the size and shape of a grain of rice, can perform hundreds of studies at the same time to examine the impact of novel treatments on some of the most difficult-to-treat brain tumours. Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, have created a device that can help in therapy testing in patients with gliomas, which are brain or spinal cord tumours. The device, which is meant to be used during standard-of-care surgery, provides unique insight into the impact of drugs on glioma tumours in a phase 1 clinical trial with no adverse effects on patients.

The effect of global warming on everyday precipitation around the world has been discovered by an international study team (POSTECH).

For the first time, scientists at the University of Johannesburg (UJ) have examined the molecular genetics of tomato plants' defence mechanisms against a destructive "young" Southern African virus. The well-known tomato yellow leaf curl virus (TYLCV) is known to be resistant to individuals who carry the Ty-1 gene. When tomato plants carrying the Ty-1 gene are infected with the virtually unheard-of tomato curly stunt virus (ToCSV), UJ researchers looked into what happens. They discovered a connection between Ty-1 gene activity, viral DNA methylation, and ToCSV tolerance in plants. The research is published in Frontiers in Plant Science.